 Russell Investments Group Ltd. acquired a new stake in NGM Biopharmaceuticals NYSE:NGM in the 1st quarter, Holdings Channel reports. The firm acquired 32,122 shares of the companys stock, valued at approximately 396,000. Other large investors also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp increased its stake ... 